0000918294-23-000144.txt : 20230526 0000918294-23-000144.hdr.sgml : 20230526 20230526121327 ACCESSION NUMBER: 0000918294-23-000144 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230331 FILED AS OF DATE: 20230526 DATE AS OF CHANGE: 20230526 PERIOD START: 20231231 FILER: COMPANY DATA: COMPANY CONFORMED NAME: T. Rowe Price Equity Series, Inc. CENTRAL INDEX KEY: 0000918294 IRS NUMBER: 000000000 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-07143 FILM NUMBER: 23965799 BUSINESS ADDRESS: STREET 1: 100 EAST PRATT STREET CITY: BALTIMORE STATE: MD ZIP: 21202 BUSINESS PHONE: 410-345-2000 MAIL ADDRESS: STREET 1: 100 EAST PRATT STREET CITY: BALTIMORE STATE: MD ZIP: 21202 FORMER COMPANY: FORMER CONFORMED NAME: PRICE T ROWE EQUITY SERIES INC DATE OF NAME CHANGE: 19940131 0000918294 S000002078 T. Rowe Price All-Cap Opportunities Portfolio C000005441 T. Rowe Price All-Cap Opportunities Portfolio QAOSWX NPORT-P 1 primary_doc.xml NPORT-P false 0000918294 XXXXXXXX S000002078 C000005441 T. ROWE PRICE EQUITY SERIES, INC. 811-07143 0000918294 549300U8GAQGX2UFFV03 100 East Pratt Street Baltimore 21202 410-345-2000 T. Rowe Price All-Cap Opportunities Portfolio S000002078 KCSFFV4S1C0KSOQDRD11 2023-12-31 2023-03-31 N 376496512.340000 1113645.330000 375382867.010000 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 1155.220000 USD N AbbVie Inc FR5LCKFTG8054YNNRU85 ABBVIE INC 00287Y109 27739.000000 NS USD 4420764.430000 1.1776681406 Long EC CORP US N 1 N N N Adobe Inc FU4LY2G4933NH2E1CP29 ADOBE INC 00724F101 5000.000000 NS USD 1926850.000000 0.5133025957 Long EC CORP US N 1 N N N Alphabet Inc 5493006MHB84DD0ZWV18 ALPHABET INC 02079K107 81469.000000 NS USD 8472776.000000 2.2571024798 Long EC CORP US N 1 N N N Amazon.com Inc ZXTILKJKG63JELOEG630 AMAZON.COM INC 023135106 39000.000000 NS USD 4028310.000000 1.0731203670 Long EC CORP US N 1 N N N Elevance Health Inc 8MYN82XMYQH89CTMTH67 ELEVANCE HEALTH INC 036752103 10572.000000 NS USD 4861111.320000 1.2949742109 Long EC CORP US N 1 N N N Apple Inc HWUPKR0MPOU8FGXBT394 APPLE INC 037833100 126682.000000 NS USD 20889861.800000 5.5649481199 Long EC CORP US N 1 N N N Argenx SE 7245009C5FZE6G9ODQ71 ARGENX SE 04016X101 4308.000000 NS USD 1605074.640000 0.4275833505 Long EC CORP NL N 1 N N N AstraZeneca PLC PY6ZZQWO2IZFZC3IOL08 ASTRAZENECA PLC 046353108 48408.000000 NS USD 3359999.280000 0.8950859443 Long EC CORP GB N 1 N N N AutoZone Inc GA3JGKJ41LJKXDN23E90 AUTOZONE INC 053332102 1651.000000 NS USD 4058405.650000 1.0811376881 Long EC CORP US N 1 N N N AvalonBay Communities Inc K9G90K85RBWD2LAGQX17 AVALONBAY COMMUNITIES INC 053484101 10876.000000 NS USD 1827820.560000 0.4869216793 Long EC CORP US N 1 N N N Best Buy Co Inc HL5XPTVRV0O8TUN5LL90 BEST BUY CO INC 086516101 26444.000000 NS USD 2069771.880000 0.5513762246 Long EC CORP US N 1 N N N BILL Holdings Inc 549300IBF9VZZIGOZW63 BILL HOLDINGS INC 090043100 11300.000000 NS USD 916882.000000 0.2442524901 Long EC CORP US N 1 N N N Booz Allen Hamilton Holding Corp 529900JPV47PIUWMA015 BOOZ ALLEN HAMILTON HOLDING CORP 099502106 29929.000000 NS USD 2774119.010000 0.7390105553 Long EC CORP US N 1 N N N Burlington Stores Inc 5299003Z37DVGKKC1W09 BURLINGTON STORES INC 122017106 6209.000000 NS USD 1254838.900000 0.3342824114 Long EC CORP US N 1 N N N CCC Intelligent Solutions Holdings Inc N/A CCC INTELLIGENT SOLUTIONS HOLDINGS INC 12510Q100 101800.000000 NS USD 913146.000000 0.2432572395 Long EC CORP US N 1 N N N Ceridian HCM Holding Inc 549300T64GVCHFJ8L449 CERIDIAN HCM HOLDING INC 15677J108 21281.000000 NS USD 1558194.820000 0.4150948157 Long EC CORP US N 1 N N N Chipotle Mexican Grill Inc N/A CHIPOTLE MEXICAN GRILL INC 169656105 3103.000000 NS USD 5300823.870000 1.4121112965 Long EC CORP US N 1 N N N Coca-Cola Co/The UWJKFUJFZ02DKWI3RY53 COCA-COLA CO/THE 191216100 103329.000000 NS USD 6409497.870000 1.7074561556 Long EC CORP US N 1 N N N Danaher Corp S4BKK9OTCEWQ3YHPFM11 DANAHER CORP 235851102 9755.000000 NS USD 2458650.200000 0.6549713415 Long EC CORP US N 1 N N N DocuSign Inc 549300Q7PVDWRZ39JG09 DOCUSIGN INC 256163106 30300.000000 NS USD 1766490.000000 0.4705835442 Long EC CORP US N 1 N N N Entegris Inc IYX6OWO7BT5DKO3BYG52 ENTEGRIS INC 29362U104 24021.000000 NS USD 1969962.210000 0.5247874592 Long EC CORP US N 1 N N N Exxon Mobil Corp J3WHBG0MTS7O8ZVMDC91 EXXON MOBIL CORP 30231G102 42788.000000 NS USD 4692132.080000 1.2499590398 Long EC CORP US N 1 N N N FMC Corp CKDHZ2X64EEBQCSP7013 FMC CORP 302491303 14811.000000 NS USD 1808867.430000 0.4818726663 Long EC CORP US N 1 N N N Meta Platforms Inc BQ4BKCS1HXDV9HN80Z93 META PLATFORMS INC 30303M102 41841.000000 NS USD 8867781.540000 2.3623298556 Long EC CORP US N 1 N N N Fiserv Inc GI7UBEJLXYLGR2C7GV83 FISERV INC 337738108 41999.000000 NS USD 4747146.970000 1.2646147140 Long EC CORP US N 1 N N N FleetCor Technologies Inc 549300DG6RR0NQSFLN74 FLEETCOR TECHNOLOGIES INC 339041105 9200.000000 NS USD 1939820.000000 0.5167577347 Long EC CORP US N 1 N N N Floor & Decor Holdings Inc 549300M5FR3N688XGQ36 FLOOR & DECOR HOLDINGS INC 339750101 13983.000000 NS USD 1373410.260000 0.3658691914 Long EC CORP US N 1 N N N General Electric Co 3C7474T6CDKPR9K6YT90 GENERAL ELECTRIC CO 369604301 46625.000000 NS USD 4457350.000000 1.1874143419 Long EC CORP US N 1 N N N Goldman Sachs Group Inc/The 784F5XWPLTWKTBV3E584 GOLDMAN SACHS GROUP INC/THE 38141G104 3853.000000 NS USD 1260354.830000 0.3357518259 Long EC CORP US N 1 N N N Airbus SE MINO79WLOO247M1IL051 AIRBUS SE 000000000 21692.000000 NS 2897346.800000 0.7718377834 Long EC CORP NL N 2 N N N HCA Healthcare Inc 529900PH4ZGUH2MNEU89 HCA HEALTHCARE INC 40412C101 8726.000000 NS USD 2300871.680000 0.6129399827 Long EC CORP US N 1 N N N Hartford Financial Services Group Inc/The IU7C3FTM7Y3BQM112U94 HARTFORD FINANCIAL SERVICES GROUP INC/THE 416515104 26188.000000 NS USD 1825041.720000 0.4861814111 Long EC CORP US N 1 N N N Hess Corp UASVRYNXNK17ULIGK870 HESS CORP 42809H107 35670.000000 NS USD 4720567.800000 1.2575341644 Long EC CORP US N 1 N N N Home Depot Inc/The QEKMOTMBBKA8I816DO57 HOME DEPOT INC/THE 437076102 15635.000000 NS USD 4614201.200000 1.2291986677 Long EC CORP US N 1 N N N Hubbell Inc 54930088VDQ6840Y6597 HUBBELL INC 443510607 2000.000000 NS USD 486620.000000 0.1296329808 Long EC CORP US N 1 N N N Humana Inc 529900YLDW34GJAO4J06 HUMANA INC 444859102 2373.000000 NS USD 1151996.580000 0.3068857642 Long EC CORP US N 1 N N N Intapp Inc N/A INTAPP INC 45827U109 9200.000000 NS USD 412528.000000 0.1098952659 Long EC CORP US N 1 N N N Intuit Inc VI90HBPH7XSFMB9E4M29 INTUIT INC 461202103 7413.000000 NS USD 3304937.790000 0.8804178561 Long EC CORP US N 1 N N N Intuitive Surgical Inc 54930052SRG011710797 INTUITIVE SURGICAL INC 46120E602 15462.000000 NS USD 3950077.140000 1.0522795490 Long EC CORP US N 1 N N N JPMorgan Chase & Co 8I5DZWZKVSZI1NUHU748 JPMORGAN CHASE & CO 46625H100 41812.000000 NS USD 5448521.720000 1.4514572184 Long EC CORP US N 1 N N N KLA Corp 549300H0BF5JCG96TJ81 KLA CORP 482480100 4700.000000 NS USD 1876099.000000 0.4997827991 Long EC CORP US N 1 N N N Karuna Therapeutics Inc N/A KARUNA THERAPEUTICS INC 48576A100 5377.000000 NS USD 976678.280000 0.2601819012 Long EC CORP US N 1 N N N Keurig Dr Pepper Inc DYTQ8KRTKO7Y2BVU5K74 KEURIG DR PEPPER INC 49271V100 58274.000000 NS USD 2055906.720000 0.5476826197 Long EC CORP US N 1 N N N Lennar Corp 529900G61XVRLX5TJX09 LENNAR CORP 526057104 15450.000000 NS USD 1623949.500000 0.4326115129 Long EC CORP US N 1 N N N Liberty Media Corp-Liberty Formula One N/A LIBERTY MEDIA CORP-LIBERTY FORMULA ONE 531229854 74266.000000 NS USD 5557324.780000 1.4804417752 Long EC CORP US N 1 N N N Eli Lilly & Co FRDRIPF3EKNDJ2CQJL29 ELI LILLY & CO 532457108 20822.000000 NS USD 7150691.240000 1.9049061288 Long EC CORP US N 1 N N N Live Nation Entertainment Inc 5493007B9BM9ZXJINO78 LIVE NATION ENTERTAINMENT INC 538034109 22804.000000 NS USD 1596280.000000 0.4252405052 Long EC CORP US N 1 N N N Lululemon Athletica Inc 549300D9GZ4BMLDW5T40 LULULEMON ATHLETICA INC 550021109 10305.000000 NS USD 3752977.950000 0.9997733727 Long EC CORP US N 1 N N N Marriott International Inc/MD 225YDZ14ZO8E1TXUSU86 MARRIOTT INTERNATIONAL INC/MD 571903202 27435.000000 NS USD 4555307.400000 1.2135096725 Long EC CORP US N 1 N N N Mastercard Inc AR5L2ODV9HN37376R084 MASTERCARD INC 57636Q104 9200.000000 NS USD 3343372.000000 0.8906565253 Long EC CORP US N 1 N N N Microsoft Corp INR2EJN1ERAN0W5ZP974 MICROSOFT CORP 594918104 68564.000000 NS USD 19767001.200000 5.2658240259 Long EC CORP US N 1 N N N Middleby Corp/The JDFO86U9VQRBKW5KYA35 MIDDLEBY CORP/THE 596278101 16861.000000 NS USD 2471991.210000 0.6585253157 Long EC CORP US N 1 N N N Molina Healthcare Inc 549300NQQCEQ46YHZ591 MOLINA HEALTHCARE INC 60855R100 19427.000000 NS USD 5196528.230000 1.3843274925 Long EC CORP US N 1 N N N Monolithic Power Systems Inc 529900TB7O85LSZ1XU31 MONOLITHIC POWER SYSTEMS INC 609839105 7554.000000 NS USD 3781079.160000 1.0072593856 Long EC CORP US N 1 N N N Morgan Stanley IGJSJL3JD5P30I6NJZ34 MORGAN STANLEY 617446448 37420.000000 NS USD 3285476.000000 0.8752333387 Long EC CORP US N 1 N N N Netflix Inc 549300Y7VHGU0I7CE873 NETFLIX INC 64110L106 11123.000000 NS USD 3842774.040000 1.0236945737 Long EC CORP US N 1 N N N NVIDIA Corp 549300S4KLFTLO7GSQ80 NVIDIA CORP 67066G104 50324.000000 NS USD 13978497.480000 3.7237974102 Long EC CORP US N 1 N N N Nutrien Ltd 5493002QQ7GD21OWF963 NUTRIEN LTD 67077M108 72076.000000 NS USD 5322812.600000 1.4179689772 Long EC CORP CA N 1 N N N Olink Holding AB 8945004Z7ZHV3LML4J27 OLINK HOLDING AB 680710100 12518.000000 NS USD 282030.540000 0.0751314364 Long EC CORP SE N 1 N N N PepsiCo Inc FJSUNZKFNQ5YPJ5OT455 PEPSICO INC 713448108 22591.000000 NS USD 4118339.300000 1.0971036938 Long EC CORP US N 1 N N N Pinterest Inc N/A PINTEREST INC 72352L106 108295.000000 NS USD 2953204.650000 0.7867180177 Long EC CORP US N 1 N N N Planet Fitness Inc 549300LLE5HUPF6H8G33 PLANET FITNESS INC 72703H101 8681.000000 NS USD 674253.270000 0.1796174864 Long EC CORP US N 1 N N N Procter & Gamble Co/The 2572IBTT8CCZW6AU4141 PROCTER & GAMBLE CO/THE 742718109 33070.000000 NS USD 4917178.300000 1.3099101563 Long EC CORP US N 1 N N N Regeneron Pharmaceuticals Inc 549300RCBFWIRX3HYQ56 REGENERON PHARMACEUTICALS INC 75886F107 5874.000000 NS USD 4826489.580000 1.2857511635 Long EC CORP US N 1 N N N T Rowe Price Government Reserve Investment Fund 5493007QR86JJLYO6D96 T ROWE PRICE GOVERNMENT RESERVE INVESTMENT FUND 76105Y109 2396478.908000 NS USD 2396478.910000 0.6384092404 Long STIV RF US N 1 N N N Roper Technologies Inc 54930003T4SXCIWVXY35 ROPER TECHNOLOGIES INC 776696106 9248.000000 NS USD 4075501.120000 1.0856918304 Long EC CORP US N 1 N N N Saia Inc 549300WNPG4N9GBOYB29 SAIA INC 78709Y105 5828.000000 NS USD 1585682.240000 0.4224173183 Long EC CORP US N 1 N N N Salesforce Inc RCGZFPDMRW58VJ54VR07 SALESFORCE INC 79466L302 17364.000000 NS USD 3468979.920000 0.9241178074 Long EC CORP US N 1 N N N Schlumberger NV 213800ZUA17OK3QLGM62 SCHLUMBERGER NV 806857108 118488.000000 NS USD 5817760.800000 1.5498205462 Long EC CORP CW N 1 N N N Charles Schwab Corp/The 549300VSGCJ7E698NM85 CHARLES SCHWAB CORP/THE 808513105 45342.000000 NS USD 2375013.960000 0.6326910919 Long EC CORP US N 1 N N N Sea Ltd 529900OM6JLLW44YKI15 SEA LTD 81141R100 27800.000000 NS USD 2406090.000000 0.6409695837 Long EC CORP KY N 1 N N N Seagen Inc N/A SEAGEN INC 81181C104 6500.000000 NS USD 1316055.000000 0.3505900550 Long EC CORP US N 1 N N N Skyward Specialty Insurance Group Inc 549300GXGXJG0YH4VN21 SKYWARD SPECIALTY INSURANCE GROUP INC 830940102 36280.000000 NS USD 793443.600000 0.2113691566 Long EC CORP US N 1 N N N Southern Copper Corp 2549007U6NAP46Q9TU15 SOUTHERN COPPER CORP 84265V105 20434.000000 NS USD 1558092.500000 0.4150675582 Long EC CORP US N 1 N N N Strategic Education Inc 0PYXF82EO1UCNGL5I740 STRATEGIC EDUCATION INC 86272C103 4300.000000 NS USD 386269.000000 0.1029000080 Long EC CORP US N 1 N N N Stryker Corp 5493002F0SC4JTBU5137 STRYKER CORP 863667101 4500.000000 NS USD 1284615.000000 0.3422146062 Long EC CORP US N 1 N N N Synopsys Inc QG7T915N9S0NY5UKNE63 SYNOPSYS INC 871607107 7322.000000 NS USD 2828122.500000 0.7533967979 Long EC CORP US N 1 N N N T-Mobile US Inc 549300QHIJYOHPACPG31 T-MOBILE US INC 872590104 74107.000000 NS USD 10733657.880000 2.8593893924 Long EC CORP US N 1 N N N Taiwan Semiconductor Manufacturing Co Ltd N/A TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD 874039100 35300.000000 NS USD 3283606.000000 0.8747351807 Long EC CORP TW N 1 N N N Tesla Inc 54930043XZGB27CTOV49 TESLA INC 88160R101 15200.000000 NS USD 3153392.000000 0.8400468634 Long EC CORP US N 1 N N N Texas Instruments Inc WDJNR2L6D8RWOEB8T652 TEXAS INSTRUMENTS INC 882508104 14113.000000 NS USD 2625159.130000 0.6993284352 Long EC CORP US N 1 N N N Thermo Fisher Scientific Inc HCHV7422L5HDJZCRFL38 THERMO FISHER SCIENTIFIC INC 883556102 9966.000000 NS USD 5744103.420000 1.5301986118 Long EC CORP US N 1 N N N TransDigm Group Inc N/A TRANSDIGM GROUP INC 893641100 3973.000000 NS USD 2928299.650000 0.7800834581 Long EC CORP US N 1 N N N Union Pacific Corp 549300LMMRSZZCZ8CL11 UNION PACIFIC CORP 907818108 10700.000000 NS USD 2153482.000000 0.5736761555 Long EC CORP US N 1 N N N UnitedHealth Group Inc 549300GHBMY8T5GXDE41 UNITEDHEALTH GROUP INC 91324P102 15515.000000 NS USD 7332233.850000 1.9532681149 Long EC CORP US N 1 N N N Veeva Systems Inc 549300YZEXPDB92M2F02 VEEVA SYSTEMS INC 922475108 13215.000000 NS USD 2428784.850000 0.6470153711 Long EC CORP US N 1 N N N VeriSign Inc LMPL4N8ZOJRMF0KOF759 VERISIGN INC 92343E102 7185.000000 NS USD 1518406.050000 0.4044952989 Long EC CORP US N 1 N N N Visa Inc 549300JZ4OKEHW3DPJ59 VISA INC 92826C839 73948.000000 NS USD 16672316.080000 4.4414163632 Long EC CORP US N 1 N N N West Pharmaceutical Services Inc 5493007NKRGM1RJQ1P16 WEST PHARMACEUTICAL SERVICES INC 955306105 9491.000000 NS USD 3288346.770000 0.8759980966 Long EC CORP US N 1 N N N Western Alliance Bancorp 5493003VJXZ5JXT9S762 WESTERN ALLIANCE BANCORP 957638109 17260.000000 NS USD 613420.400000 0.1634119332 Long EC CORP US N 1 N N N Workiva Inc 529900RTOQ8GRWHY1O58 WORKIVA INC 98139A105 15994.000000 NS USD 1637945.540000 0.4363399835 Long EC CORP US N 1 N N N Chubb Ltd E0JAN6VLUDI1HITHT809 CHUBB LTD 000000000 43479.000000 NS USD 8442752.220000 2.2491043044 Long EC CORP CH N 1 N N N ASML Holding NV 724500Y6DUVHQD6OXN27 ASML HOLDING NV 000000000 6027.000000 NS USD 4102639.170000 1.0929212627 Long EC CORP NL N 1 N N N TechnipFMC PLC 549300D5I93QWCJTCK36 TECHNIPFMC PLC 000000000 237651.000000 NS USD 3243936.150000 0.8641673436 Long EC CORP GB N 1 N N N Seadrill Ltd 213800EQ6L456U2JCO89 SEADRILL LTD 000000000 33115.000000 NS USD 1329898.400000 0.3542778632 Long EC CORP BM N 1 N N N Linde PLC 5299003QR1WT0EF88V51 LINDE PLC 000000000 18800.000000 NS USD 6682272.000000 1.7801217336 Long EC CORP IE N 1 N N N Adyen NV 724500973ODKK3IFQ447 ADYEN NV 000000000 1677.000000 NS 2672180.080000 0.7118545663 Long EC CORP NL N 2 N N N N/A N/A WAYMO LLC SER A-2 CVT PFD UNITS PP 000000000 8696.000000 NS USD 410277.280000 0.1092956861 Long EP CORP US Y 3 N N N N/A N/A CANVA SERIES A CVT PFD STOCK PP TC0R8VGD3 12.000000 NS USD 6621.600000 0.0017639590 Long EP CORP US Y 3 N N N N/A N/A TREELINE BIO SER A CVT PFD STOCK PP 000000000 7690.000000 NS USD 60193.480000 0.0160352230 Long EP CORP US Y 3 N N N Caris Life Sciences Inc 549300LX5LO78M5VPY43 CARIS LIFE SER D CVT PFD STOCK PP TC13PNHL5 36019.000000 NS USD 237005.020000 0.0631368773 Long EP CORP US Y 3 N N N N/A N/A CANVA COMMON STOCK PP TC1HS9QX6 205.000000 NS USD 113119.000000 0.0301343002 Long EC CORP US Y 3 N N N N/A N/A RAD POWER BIKES SER D CVT PFD STOCK PP TC1WCLZE5 92335.000000 NS USD 394270.450000 0.1050315517 Long EP CORP US Y 3 N N N N/A N/A REDWOOD MATERIALS SER C CVT STOCK PP TC25HIZF2 9305.000000 NS USD 471112.150000 0.1255017720 Long EP CORP US Y 3 N N N N/A N/A ABL SPACE SYSTEMS SER B-2 CVT PFD STK PP TC3SUK8I5 3407.000000 NS USD 109398.770000 0.0291432507 Long EP CORP US Y 3 N N N Bytedance Ltd 300300NIFA1100061063 BYTEDANCE LTD CVT PFD SR E PP 000000000 7838.000000 NS USD 1311685.380000 0.3494260115 Long EP CORP US Y 3 N N N N/A N/A ABL SPACE SYSTEMS SER B CVT PFD STOCK PP TC6KIBHA0 12016.000000 NS USD 385833.760000 0.1027840623 Long EP CORP US Y 3 N N N PAX Labs Inc 549300FKJA0AEKUHVG68 PAX LABS CLASS A COMMON PP 000000000 128372.000000 NS USD 61618.560000 0.0164148568 Long EC CORP US Y 3 N N N 2023-03-31 T. ROWE PRICE EQUITY SERIES, INC. /s/ Alan Dupski Alan Dupski Treasurer & Vice President XXXX NPORT-EX 2 70D2TRP033123.htm T. ROWE PRICE EQUITY SERIES, INC.
T.
ROWE
PRICE
All-Cap
Opportunities
Portfolio
March
31,
2023
(Unaudited)
1
Portfolio
of
Investments
Shares
$
Value
(Cost
and
value
in
$000s)
COMMON
STOCKS
98.7%
COMMUNICATION
SERVICES
11.9%
Entertainment
3.6%
Liberty
Media-Liberty
Formula
One,
Class
C (1)
74,266‌
5,557‌
Live
Nation
Entertainment (1)
22,804‌
1,596‌
Netflix (1)
11,123‌
3,843‌
Sea,
ADR (1)
27,800‌
2,406‌
13,402‌
Interactive
Media
&
Services
5.4%
Alphabet,
Class
C (1)
81,469‌
8,473‌
Meta
Platforms,
Class
A (1)
41,841‌
8,868‌
Pinterest,
Class
A (1)
108,295‌
2,953‌
20,294‌
Wireless
Telecommunication
Services
2.9%
T-Mobile
U.S. (1)
74,107‌
10,734‌
10,734‌
Total
Communication
Services
44,430‌
CONSUMER
DISCRETIONARY
9.8%
Automobiles
0.8%
Tesla (1)
15,200‌
3,153‌
3,153‌
Broadline
Retail
1.1%
Amazon.com (1)
39,000‌
4,028‌
4,028‌
Diversified
Consumer
Services
0.1%
Strategic
Education 
4,300‌
386‌
386‌
Hotels,
Restaurants
&
Leisure
2.8%
Chipotle
Mexican
Grill (1)
3,103‌
5,301‌
Marriott
International,
Class
27,435‌
4,555‌
Planet
Fitness,
Class
A (1)
8,681‌
674‌
10,530‌
Household
Durables
0.4%
Lennar,
Class
15,450‌
1,624‌
1,624‌
Specialty
Retail
3.6%
AutoZone (1)
1,651‌
4,058‌
Best
Buy 
26,444‌
2,070‌
Burlington
Stores (1)
6,209‌
1,255‌
Floor
&
Decor
Holdings,
Class
A (1)
13,983‌
1,374‌
Home
Depot 
15,635‌
4,614‌
13,371‌
Textiles,
Apparel
&
Luxury
Goods
1.0%
Lululemon
Athletica (1)
10,305‌
3,753‌
3,753‌
Total
Consumer
Discretionary
36,845‌
Shares
$
Value
(Cost
and
value
in
$000s)
CONSUMER
STAPLES
4.7%
Beverages
3.4%
Coca-Cola 
103,329‌
6,410‌
Keurig
Dr
Pepper 
58,274‌
2,056‌
PepsiCo 
22,591‌
4,118‌
12,584‌
Household
Products
1.3%
Procter
&
Gamble 
33,070‌
4,917‌
4,917‌
Total
Consumer
Staples
17,501‌
ENERGY
5.3%
Energy
Equipment
&
Services
2.8%
Schlumberger 
118,488‌
5,818‌
Seadrill (1)
33,115‌
1,330‌
TechnipFMC (1)
237,651‌
3,244‌
10,392‌
Oil,
Gas
&
Consumable
Fuels
2.5%
Exxon
Mobil 
42,788‌
4,692‌
Hess 
35,670‌
4,721‌
9,413‌
Total
Energy
19,805‌
FINANCIALS
14.2%
Banks
1.6%
JPMorgan
Chase 
41,812‌
5,448‌
Western
Alliance
Bancorp 
16,260‌
578‌
6,026‌
Capital
Markets
1.8%
Charles
Schwab 
45,342‌
2,375‌
Goldman
Sachs
Group 
3,853‌
1,260‌
Morgan
Stanley 
37,420‌
3,286‌
6,921‌
Financial
Services
7.8%
Adyen
(EUR) (1)
1,677‌
2,672‌
Fiserv (1)
41,999‌
4,747‌
FleetCor
Technologies (1)
9,200‌
1,940‌
Mastercard,
Class
9,200‌
3,344‌
Visa,
Class
73,948‌
16,672‌
29,375‌
Insurance
3.0%
Chubb 
43,479‌
8,443‌
Hartford
Financial
Services
Group 
26,188‌
1,825‌
Skyward
Specialty
Insurance
Group (1)
36,280‌
793‌
11,061‌
Total
Financials
53,383‌
HEALTH
CARE
17.1%
Biotechnology
3.5%
AbbVie 
27,739‌
4,421‌
Argenx,
ADR (1)
4,308‌
1,605‌
Karuna
Therapeutics (1)
5,377‌
977‌
Regeneron
Pharmaceuticals (1)
5,874‌
4,826‌
T.
ROWE
PRICE
All-Cap
Opportunities
Portfolio
2
Shares
$
Value
(Cost
and
value
in
$000s)
Seagen (1)
6,500‌
1,316‌
13,145‌
Health
Care
Equipment
&
Supplies
1.4%
Intuitive
Surgical (1)
15,462‌
3,950‌
Pax
Labs,
Class
A,
Acquisition
Date:
4/18/19,
Cost $483 (1)(2)(3)
128,372‌
62‌
Stryker 
4,500‌
1,284‌
5,296‌
Health
Care
Providers
&
Services
5.6%
Elevance
Health 
10,572‌
4,861‌
HCA
Healthcare 
8,726‌
2,301‌
Humana 
2,373‌
1,152‌
Molina
Healthcare (1)
19,427‌
5,197‌
UnitedHealth
Group 
15,515‌
7,332‌
20,843‌
Health
Care
Technology
0.7%
Veeva
Systems,
Class
A (1)
13,215‌
2,429‌
2,429‌
Life
Sciences
Tools
&
Services
3.1%
Danaher 
9,755‌
2,459‌
Olink
Holding,
ADR (1)
12,518‌
282‌
Thermo
Fisher
Scientific 
9,966‌
5,744‌
West
Pharmaceutical
Services 
9,491‌
3,288‌
11,773‌
Pharmaceuticals
2.8%
AstraZeneca,
ADR 
48,408‌
3,360‌
Eli
Lilly 
20,822‌
7,151‌
10,511‌
Total
Health
Care
63,997‌
INDUSTRIALS
&
BUSINESS
SERVICES
6.4%
Aerospace
&
Defense
1.6%
Airbus
(EUR) 
21,692‌
2,898‌
TransDigm
Group 
3,973‌
2,928‌
5,826‌
Electrical
Equipment
0.1%
Hubbell 
2,000‌
487‌
487‌
Ground
Transportation
1.0%
Saia (1)
5,828‌
1,586‌
Union
Pacific 
10,700‌
2,153‌
3,739‌
Industrial
Conglomerates
2.3%
General
Electric 
46,625‌
4,457‌
Roper
Technologies 
9,248‌
4,076‌
8,533‌
Machinery
0.7%
Middleby (1)
16,861‌
2,472‌
2,472‌
Shares
$
Value
(Cost
and
value
in
$000s)
Professional
Services
0.7%
Booz
Allen
Hamilton
Holding 
29,929‌
2,774‌
2,774‌
Total
Industrials
&
Business
Services
23,831‌
INFORMATION
TECHNOLOGY
24.7%
IT
Services
0.4%
VeriSign (1)
7,185‌
1,518‌
1,518‌
Semiconductors
&
Semiconductor
Equipment
8.4%
ASML
Holding 
6,027‌
4,103‌
Entegris 
24,021‌
1,970‌
KLA 
4,700‌
1,876‌
Monolithic
Power
Systems 
7,554‌
3,781‌
NVIDIA 
50,324‌
13,978‌
Taiwan
Semiconductor
Manufacturing,
ADR 
35,300‌
3,284‌
Texas
Instruments 
14,113‌
2,625‌
31,617‌
Software
10.3%
Adobe (1)
5,000‌
1,927‌
BILL
Holdings (1)
11,300‌
917‌
Canva,
Acquisition
Date:
8/16/21
-
11/4/21,
Cost $349 (1)(2)(3)
205‌
113‌
CCC
Intelligent
Solutions
Holdings (1)
101,800‌
913‌
Ceridian
HCM
Holding (1)
21,281‌
1,558‌
DocuSign (1)
30,300‌
1,766‌
Intapp (1)
9,200‌
413‌
Intuit 
7,413‌
3,305‌
Microsoft 
68,564‌
19,767‌
Salesforce (1)
17,364‌
3,469‌
Synopsys (1)
7,322‌
2,828‌
Workiva (1)
15,994‌
1,638‌
38,614‌
Technology
Hardware,
Storage
&
Peripherals
5.6%
Apple 
126,682‌
20,890‌
20,890‌
Total
Information
Technology
92,639‌
MATERIALS
4.1%
Chemicals
3.7%
FMC 
14,811‌
1,809‌
Linde 
18,800‌
6,682‌
Nutrien 
72,076‌
5,323‌
13,814‌
Metals
&
Mining
0.4%
Southern
Copper 
20,434‌
1,558‌
1,558‌
Total
Materials
15,372‌
T.
ROWE
PRICE
All-Cap
Opportunities
Portfolio
3
Shares
$
Value
(Cost
and
value
in
$000s)
REAL
ESTATE
0.5%
Residential
Real
Estate
Investment
Trusts
0.5%
AvalonBay
Communities,
REIT 
10,876‌
1,828‌
Total
Real
Estate
1,828‌
Total
Common
Stocks
(Cost
$291,235)
369,631‌
CONVERTIBLE
PREFERRED
STOCKS
0.9%
COMMUNICATION
SERVICES
0.4%
Interactive
Media
&
Services
0.4%
ByteDance,
Series
E,
Acquisition
Date:
7/8/19,
Cost $386 (1)(2)(3)
7,838‌
1,312‌
Total
Communication
Services
1,312‌
CONSUMER
DISCRETIONARY
0.1%
Leisure
Products
0.1%
Rad
Power
Bikes,
Series
D,
Acquisition
Date:
9/16/21,
Cost $885 (1)(2)(3)
92,335‌
395‌
Total
Consumer
Discretionary
395‌
HEALTH
CARE
0.1%
Biotechnology
0.1%
Caris
Life
Sciences,
Series
D,
Acquisition
Date:
5/11/21,
Cost $292 (1)(2)(3)
36,019‌
237‌
Treeline,
Series
A,
Acquisition
Date:
9/26/22,
Cost $60 (1)(2)(3)
7,690‌
60‌
Total
Health
Care
297‌
Shares
$
Value
(Cost
and
value
in
$000s)
INDUSTRIALS
&
BUSINESS
SERVICES
0.1%
Aerospace
&
Defense
0.1%
ABL
Space
Systems,
Series
B,
Acquisition
Date:
3/24/21,
Cost $541 (1)(2)(3)
12,016‌
386‌
ABL
Space
Systems,
Series
B-2,
Acquisition
Date:
10/22/21,
Cost $232 (1)(2)(3)
3,407‌
109‌
Total
Industrials
&
Business
Services
495‌
INFORMATION
TECHNOLOGY
0.1%
Software
0.1%
Canva,
Series
A,
Acquisition
Date:
11/4/21,
Cost $20 (1)(2)(3)
12‌
7‌
Waymo,
Series
A-2,
Acquisition
Date:
5/8/20,
Cost $747 (1)(2)(3)
8,696‌
410‌
Total
Information
Technology
417‌
MATERIALS
0.1%
Chemicals
0.1%
Redwood
Materials,
Series
C,
Acquisition
Date:
5/28/21,
Cost $441 (1)(2)(3)
9,305‌
471‌
Total
Materials
471‌
Total
Convertible
Preferred
Stocks
(Cost
$3,604)
3,387‌
SHORT-TERM
INVESTMENTS
0.6%
Money
Market
Funds
0.6%
T.
Rowe
Price
Government
Reserve
Fund,
4.82% (4)(5)
2,418,394‌
2,418‌
Total
Short-Term
Investments
(Cost
$2,418)
2,418‌
Total
Investments
in
Securities
100.2%
(Cost
$297,257)
$
375,436‌
Other
Assets
Less
Liabilities
(0.2)%
(616‌)
Net
Assets
100.0%
$
374,820‌
Shares
are
denominated
in
U.S.
dollars
unless
otherwise
noted.
(1)
Non-income
producing
(2)
Security
cannot
be
offered
for
public
resale
without
first
being
registered
under
the
Securities
Act
of
1933
and
related
rules
("restricted
security").
Acquisition
date
represents
the
day
on
which
an
enforceable
right
to
acquire
such
security
is
obtained
and
is
presented
along
with
related
cost
in
the
security
description.
The
fund
may
have
registration
rights
for
certain
restricted
securities.
Any
costs
related
to
such
registration
are
generally
borne
by
the
issuer.
The
aggregate
value
of
restricted
securities
(excluding
144A
holdings)
at
period
end
amounts
to
$3,562
and
represents
1.0%
of
net
assets.
(3)
Level
3
in
fair
value
hierarchy.
(4)
Seven-day
yield
(5)
Affiliated
Companies
ADR
American
Depositary
Receipts
EUR
Euro
REIT
A
domestic
Real
Estate
Investment
Trust
whose
distributions
pass-through
with
original
tax
character
to
the
shareholder
T.
ROWE
PRICE
All-Cap
Opportunities
Portfolio
4
The
accompanying
notes
are
an
integral
part
of
this
Portfolio
of
Investments.
AFFILIATED
COMPANIES
($000s)
The
fund
may
invest
in
certain
securities
that
are
considered
affiliated
companies.
As
defined
by
the
1940
Act,
an
affiliated
company
is
one
in
which
the
fund
owns
5%
or
more
of
the
outstanding
voting
securities,
or
a
company
that
is
under
common
ownership
or
control.
The
following
securities
were
considered
affiliated
companies
for
all
or
some
portion
of
the
three
months
ended
March
31,
2023.
Net
realized
gain
(loss),
investment
income,
change
in
net
unrealized
gain/loss,
and
purchase
and
sales
cost
reflect
all
activity
for
the
period
then
ended.
Affiliate
Net
Realized
Gain
(Loss)
Change
in
Net
Unrealized
Gain/Loss
Investment
Income
T.
Rowe
Price
Government
Reserve
Fund,
4.82%
$
—‌#
$
—‌
$
73‌+
Supplementary
Investment
Schedule
Affiliate
Value
12/31/22
Purchase
Cost
Sales
Cost
Value
03/31/23
T.
Rowe
Price
Government
Reserve
Fund,
4.82%
$
12,579‌
 ¤
 ¤
$
2,418‌^
#
Capital
gain
distributions
from
underlying
Price
funds
represented
$0
of
the
net
realized
gain
(loss).
+
Investment
income
comprised
$73
of
dividend
income
and
$0
of
interest
income.
¤
Purchase
and
sale
information
not
shown
for
cash
management
funds.
^
The
cost
basis
of
investments
in
affiliated
companies
was
$2,418.
T.
ROWE
PRICE
All-Cap
Opportunities
Portfolio
Unaudited
5
Notes
to
Portfolio
of
Investments
T.
Rowe
Price
All-Cap
Opportunities
Portfolio (the
fund) is
registered
under
the
Investment
Company
Act
of
1940
(the
1940
Act)
as
an
open-end
management
investment
company
and
follows
accounting
and
reporting
guidance
of
the
Financial
Accounting
Standards
Board
Accounting
Standards
Codification
Topic
946.
The
accompanying
Portfolio
of
Investments
was
prepared
in
accordance
with
accounting
principles
generally
accepted
in
the
United
States
of
America
(GAAP).
For
additional
information
on
the
fund’s
significant
accounting
policies
and
investment
related
disclosures,
please
refer
to
the
fund’s most
recent
semiannual
or
annual
shareholder
report
and
its
prospectus. 
VALUATION 
Fair
Value
  The
fund’s
financial
instruments
are
valued
at
the
close
of
the
New
York
Stock
Exchange
(NYSE),
normally
4
p.m.
ET,
each
day
the
NYSE
is
open
for
business,
and
are
reported
at
fair
value,
which
GAAP
defines
as
the
price
that
would
be
received
to
sell
an
asset
or
paid
to
transfer
a
liability
in
an
orderly
transaction
between
market
participants
at
the
measurement
date. The fund’s
Board
of
Directors
(the
Board)
has
designated
T.
Rowe
Price
Associates,
Inc.
as
the
fund’s
valuation
designee
(Valuation
Designee).
Subject
to
oversight
by
the
Board,
the
Valuation
Designee
performs
the
following
functions
in
performing
fair
value
determinations:
assesses
and
manages
valuation
risks;
establishes
and
applies
fair
value
methodologies;
tests
fair
value
methodologies;
and
evaluates
pricing
vendors
and
pricing
agents.
The
duties
and
responsibilities
of
the
Valuation
Designee
are
performed
by
its
Valuation
Committee. The
Valuation
Designee provides
periodic
reporting
to
the
Board
on
valuation
matters.
Various
valuation
techniques
and
inputs
are
used
to
determine
the
fair
value
of
financial
instruments.
GAAP
establishes
the
following
fair
value
hierarchy
that
categorizes
the
inputs
used
to
measure
fair
value:
Level
1
quoted
prices
(unadjusted)
in
active
markets
for
identical
financial
instruments
that
the
fund
can
access
at
the
reporting
date
Level
2
inputs
other
than
Level
1
quoted
prices
that
are
observable,
either
directly
or
indirectly
(including,
but
not
limited
to,
quoted
prices
for
similar
financial
instruments
in
active
markets,
quoted
prices
for
identical
or
similar
financial
instruments
in
inactive
markets,
interest
rates
and
yield
curves,
implied
volatilities,
and
credit
spreads)
Level
3
unobservable
inputs
(including
the Valuation
Designee’s assumptions
in
determining
fair
value)
Observable
inputs
are
developed
using
market
data,
such
as
publicly
available
information
about
actual
events
or
transactions,
and
reflect
the
assumptions
that
market
participants
would
use
to
price
the
financial
instrument.
Unobservable
inputs
are
those
for
which
market
data
are
not
available
and
are
developed
using
the
best
information
available
about
the
assumptions
that
market
participants
would
use
to
price
the
financial
instrument.
GAAP
requires
valuation
techniques
to
maximize
the
use
of
relevant
observable
inputs
and
minimize
the
use
of
unobservable
inputs.
When
multiple
inputs
are
used
to
derive
fair
value,
the
financial
instrument
is
assigned
to
the
level
within
the
fair
value
hierarchy
based
on
the
lowest-level
input
that
is
significant
to
the
fair
value
of
the
financial
instrument.
Input
levels
are
not
necessarily
an
indication
of
the
risk
or
liquidity
associated
with
financial
instruments
at
that
level
but
rather
the
degree
of
judgment
used
in
determining
those
values.
Valuation
Techniques 
Equity
securities,
including
exchange-traded
funds, listed
or
regularly
traded
on
a
securities
exchange
or
in
the
over-the-counter
(OTC)
market
are
valued
at
the
last
quoted
sale
price
or,
for
certain
markets,
the
official
closing
price
at
the
time
the
valuations
are
made.
OTC
Bulletin
Board
securities
are
valued
at
the
mean
of
the
closing
bid
and
asked
prices.
A
security
that
is
listed
or
traded
on
more
than
one
exchange
is
valued
at
the
quotation
on
the
exchange
determined
to
be
the
primary
market
for
such
security.
Listed
securities
not
traded
on
a
particular
day
are
valued
at
the
mean
of
the
closing
bid
and
asked
prices
for
domestic
securities
and
the
last
quoted
sale
or
closing
price
for
international
securities.
The
last
quoted
prices
of
non-U.S.
equity
securities
may
be
adjusted
to
reflect
the
fair
value
of
such
securities
at
the
close
of
the
NYSE,
if
the Valuation
Designee
determines
that
developments
between
the
close
of
a
foreign
market
and
the
close
of
the
NYSE
will
affect
the
value
of
some
or
all
of its portfolio
securities.
Each
business
day,
the
Valuation
Designee uses
information
from
outside
pricing
services
to
evaluate
the
quoted
prices
of
portfolio
securities
and,
if
appropriate,
decide whether
it
is
necessary
to
adjust
quoted
prices
to
reflect
fair
value
by
reviewing
a
variety
of
factors,
including
developments
in
foreign
markets,
the
performance
of
U.S.
securities
markets,
and
the
performance
of
instruments
trading
in
U.S.
markets
that
represent
foreign
securities
and
baskets
of
foreign
securities. The Valuation
Designee
uses
outside
pricing
services
to
provide
it
with
quoted
prices
and
information
to
evaluate
or
adjust
those
prices.
The Valuation
Designee
cannot
predict
how
often
it
will
use
quoted
prices
and
how
often
it
will
determine
it
necessary
to
adjust
those
prices
to
reflect
fair
value.
T.
ROWE
PRICE
All-Cap
Opportunities
Portfolio
6
Investments
denominated
in
foreign
currencies
are
translated
into
U.S.
dollar
values
each
day
at
the
prevailing
exchange
rate,
using
the
mean
of
the
bid
and
asked
prices
of
such
currencies
against
U.S.
dollars
as
provided
by
an
outside
pricing
service.
Investments
in
mutual
funds
are
valued
at
the
mutual
fund’s
closing
NAV
per
share
on
the
day
of
valuation.
Investments
for
which
market
quotations are
not
readily
available
or
deemed
unreliable
are
valued
at
fair
value
as
determined
in
good
faith
by
the
Valuation
Designee.
The
Valuation
Designee
has
adopted
methodologies
for
determining
the
fair
value
of
investments
for
which
market
quotations
are
not
readily
available
or
deemed
unreliable,
including
the
use
of
other
pricing
sources.
Factors
used
in
determining
fair
value
vary
by
type
of
investment
and
may
include
market
or
investment
specific
considerations.
The
Valuation
Designee typically
will
afford
greatest
weight
to
actual
prices
in
arm’s
length
transactions,
to
the
extent
they
represent
orderly
transactions
between
market
participants,
transaction
information
can
be
reliably
obtained,
and
prices
are
deemed
representative
of
fair
value.
However,
the
Valuation
Designee may
also
consider
other
valuation
methods
such
as
market-based
valuation
multiples;
a
discount
or
premium
from
market
value
of
a
similar,
freely
traded
security
of
the
same
issuer;
discounted
cash
flows;
yield
to
maturity;
or
some
combination.
Fair
value
determinations
are
reviewed
on
a
regular
basis.
Because
any
fair
value
determination
involves
a
significant
amount
of
judgment,
there
is
a
degree
of
subjectivity
inherent
in
such
pricing
decisions. Fair
value
prices
determined
by
the
Valuation
Designee could
differ
from
those
of
other
market
participants,
and
it
is
possible
that
the
fair
value
determined
for
a
security
may
be
materially
different
from
the
value
that
could
be
realized
upon
the
sale
of
that
security.
Valuation
Inputs
  The
following
table
summarizes
the
fund’s
financial
instruments,
based
on
the
inputs
used
to
determine
their
fair
values
on
March
31,
2023
(for
further
detail
by
category,
please
refer
to
the
accompanying
Portfolio
of
Investments):
OTHER
MATTERS 
Unpredictable
events
such
as
environmental
or
natural
disasters,
war,
terrorism,
pandemics,
outbreaks
of
infectious
diseases,
and
similar
public
health
threats
may
significantly
affect
the
economy
and
the
markets
and
issuers
in
which
the fund
invests.
Certain
events
may
cause
instability
across
global
markets,
including
reduced
liquidity
and
disruptions
in
trading
markets,
while
some
events
may
affect
certain
geographic
regions,
countries,
sectors,
and
industries
more
significantly
than
others,
and
exacerbate
other
pre-existing
political,
social,
and
economic
risks.
Since
2020,
a
novel
strain
of
coronavirus
(COVID-19)
has
resulted
in
disruptions
to
global
business
activity
and
caused
significant
volatility
and
declines
in
global
financial
markets.
In
February
2022,
Russian
forces
entered
Ukraine
and
commenced
an
armed
conflict
leading
to
economic
sanctions
being
imposed
on
Russia
and
certain
of
its
citizens,
creating
impacts
on
Russian-related
stocks
and
debt
and
greater
volatility
in
global
markets.
In
March
2023,
the
collapse
of
some
US
regional
and
global
banks
as
well
as
overall
concerns
around
the
soundness
and
stability
of
the
global
banking
sector
has
sparked
concerns
of
a
broader
financial
crisis
impacting
the
overall
global
banking
sector.
In
certain
cases,
government
agencies
have
assumed
control
or
otherwise
intervened
in
the
operations
of
certain
banks
due
to
liquidity
and
solvency
concerns.
The
extent
of
impact
of
these
events
on
the
US
and
global
markets
is
highly
uncertain.
These
are
recent
examples
of
global
events
which
may
have
a
negative
impact
on
the
values
of
certain
portfolio
holdings
or
the
fund’s
overall
performance.
Management
is
actively
monitoring
the
risks
and
financial
impacts
arising
from
these
events.
E302-054Q1
03/23
($000s)
Level
1
Level
2
Level
3
Total
Value
Assets
Common
Stocks
$
363,886‌
$
5,570‌
$
175‌
$
369,631‌
Convertible
Preferred
Stocks
—‌
—‌
3,387‌
3,387‌
Short-Term
Investments
2,418‌
—‌
—‌
2,418‌
Total
$
366,304‌
$
5,570‌
$
3,562‌
$
375,436‌